Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

about

Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

Item

http://www.wikidata.org/entity/Q47684583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@en

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@nl

type

Item

label

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@en

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@nl

prefLabel

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@en

Efficacy and safety of 153Sm-E ...... : a large single-center study.

@nl

P1476

Efficacy and safety of 153Sm-E ...... s: a large single-center study

@en

P2093

Anaïs Olivier

http://www.w3.org/2001/XMLSchema#string

Aurore Oudoux

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Tresch-Bruneel

http://www.w3.org/2001/XMLSchema#string

Hélène Kolesnikov-Gauthier

http://www.w3.org/2001/XMLSchema#string

Nathalie Lemoine

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.

Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases.

Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy.

Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.

(153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer.

P2888

s00520-017-3885-3

P304

751-758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-3885-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Penel

P577

2017-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28920149

http://www.w3.org/2001/XMLSchema#string